Publicacions en què col·labora amb RODRIGO BARDERAS MANCHADO (11)

2023

  1. In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression

    Cellular Oncology, Vol. 46, Núm. 3, pp. 697-715

2022

  1. In-depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer

    Molecular Oncology, Vol. 16, Núm. 14, pp. 2672-2692

  2. Seroreactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic Target

    Diabetes, Vol. 71, Núm. 3, pp. 497-510

2021

  1. Multiplexed Biosensing Diagnostic Platforms Detecting Autoantibodies to Tumor-Associated Antigens from Exosomes Released by CRC Cells and Tissue Samples Showed High Diagnostic Ability for Colorectal Cancer

    Engineering, Vol. 7, Núm. 10, pp. 1393-1412

  2. Protein Microarrays for Ocular Diseases

    Methods in Molecular Biology (Humana Press Inc.), pp. 239-265

2020

  1. Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis

    Journal of Proteomics, Vol. 214

  2. Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform

    Theranostics, Vol. 10, Núm. 7, pp. 3022-3034

  3. Protein microarrays: Valuable tools for ocular diseases research

    Current Medicinal Chemistry, Vol. 27, Núm. 27, pp. 4549-4566

2019

  1. The specific seroreactivity to ∆Np73 isoforms shows higher diagnostic ability in colorectal cancer patients than the canonical p73 protein

    Scientific reports, Vol. 9, Núm. 1, pp. 13547

2017

  1. Protein microarrays in neurodegenerative diseases

    Neuromethods (Humana Press Inc.), pp. 43-62

2016

  1. Toward liquid biopsy: Determination of the humoral immune response in cancer patients using halotag fusion protein-modified electrochemical bioplatforms

    Analytical Chemistry, Vol. 88, Núm. 24, pp. 12339-12345